Dr. Giuseppe Scionti is an Assistant Professor of Biomaterials and Tissue Engineering at the Biomaterials, Biomechanics and Tissue Engineering research group of the Department of Material Science and Metallurgical Engineering, at the Technical University of Catalonia in Barcelona, Spain. He published multiple articles in high-impact international journals, and counts with several publications and oral presentations in international conferences. In 2014, he filed a patent on the development of magnetic field sensitive biomaterials, based on the incorporation of biocompatible nanoparticles to generate the first smart magnetorheological scaffolds for tissue engineering applications, whose mechanical properties can be controlled by noncontact forces. His academic background includes (i) a PhD in Biomedicine cum laude, Universidad de Granada, Granada, Spain, 2014, (ii) a Master in Tissue Engineering, Universidad de Granada, Granada, Spain, 2012, (iii) a Master of Science in Biomedical Engineering, Chalmers University of Technology, Göteborg, Sweden, 2010, and (iv) a Bachelor of Science in Biomedical Engineering, Politecnico di Milano, Milano, Italy, 2008. He has been nominated Academic Member of the Eastern Andalusia Royal Academy of Medicine for winning the 2012 Award of the academy with a study on the in vivo evaluation of a novel nano-technological human artificial skin model. He is reviewer for the scientific journals Stem Cells International, Plos One and Actualidad Medica. From 2015, he is an elected Judge for the MIT Technology Review Innovators Under 35 Awards of the MIT Technology Review organization (Cambridge, USA).
His research focuses on the design and development of different 3D bioengineered tissue models for multiple biomedical applications, and on the generation of novel biomimetic materials with defined microstructure and physical properties, using a variety of natural and synthetic biomaterials. Currently, his research activities are focused on the generation of advanced biomaterials and bioinks through state of the art 3D bioprinting technologies for the development of novel tissue engineered models for soft and hard tissues regeneration and neovascularization.